The 38th annual cystic fibrosis symposium

Join the Royal Society of Medicine (RSM) Paediatrics & Child Health Section for this long-standing annual meeting, bringing together the UK cystic fibrosis multidisciplinary community for a day of education, networking and the latest developments in cystic fibrosis care. The programme will provide an overview of the most important advances from the past 12 months, with a particular focus on new research, emerging evidence and areas of current clinical interest.

As cystic fibrosis care continues to evolve in the era of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy, this meeting will present the latest findings from the highly anticipated CF-STORM and CF-SPIT/CF-homeSPIT clinical trials, alongside expert updates on communicating a diagnosis of cystic fibrosis and the use of CFTR modulators during pregnancy. Through the Fellows' rounds and the popular "Year in Review" session, delegates will learn from complex clinical cases and support the next generation of cystic fibrosis clinicians.

Why attend?

• Hear from leading experts including Professor Julian Forton, Professor Kevin Southern, Professor Irene Roberts and Dr Gwyneth Davies
• Hear the latest results from the highly anticipated CF-STORM and CF-SPIT/CF-homeSPIT clinical trials
• Gain expert updates on respiratory management, diagnosis and the evolving role of CFTR modulator therapy
• Explore current guidance on CFTR modulators during pregnancy and communicating a diagnosis of cystic fibrosis
• Learn from complex case presentations in the Fellows' rounds and hear the popular “Year in Review" session
• Network with colleagues from across the UK cystic fibrosis multidisciplinary community

Aims of the event

• Provide an overview of recent developments and emerging evidence in cystic fibrosis care
• Explore current best practice in the diagnosis and management of children and adults with cystic fibrosis
• Support multidisciplinary learning through expert discussion, clinical cases and shared experience

Learning outcomes
By attending this meeting, participants will be able to:

• Describe the latest findings from the CF-STORM and CF-SPIT/CF-homeSPIT clinical trials and evaluate their implications for respiratory management in the era of CFTR modulator therapy
• Explain current approaches to communicating a cystic fibrosis diagnosis and apply expert guidance on the use of CFTR modulators during pregnancy, including fetal treatment and infant monitoring
• Analyse complex clinical cases presented in the Fellows' rounds and apply learning from multidisciplinary discussion to improve the care of children and adults with cystic fibrosis
• Identify emerging developments across the cystic fibrosis field and evaluate how these can be integrated into clinical practice

Who should attend?
This meeting is suitable for:

• Consultants, SAS doctors and resident doctors working in cystic fibrosis care
• Paediatricians and respiratory physicians
• Specialist nurses, physiotherapists, dietitians and psychologists working within cystic fibrosis multidisciplinary teams
• Allied health professionals involved in the care of people with cystic fibrosis
• Medical students with an interest in cystic fibrosis

Call for Fellows’ round:

• The Fellows’ round session will include 4 cases from paediatric and adult departments. Each talk will be allocated 20 minutes, case presentations should last 10-15 minutes to allow 5-10 minutes for discussion.
• If you would like to submit a case, please send a single side of A4 outlining the case and highlighting discussion points to: [email protected] and [email protected]
• Deadline for case submission: Sunday 27 September 2026

Follow us on:

Facebook 
Instagram
LinkedIn
Twitter
YouTube